GENEVA, Sept. 18 -- AGIOS PHARMACEUTICALS, INC. filed a patent application (US2026/017660) for “(PYRAZOLO[1,5-A]PYRIDIN-2-YL)-1,4,6,7-TETRAHYDRO-5H-IMIDAZO[4,5-C]-PYRIDINE DERIVATIVES USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS”. With publication no. WO/2026/187877, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 519/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....